Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Stonehedge Bioresources is a Canadian biotechnology company specializing in the cultivation, genetic development, and extraction of cannabis-derived compounds. Based in Ontario, the company operates as a licensed producer under Health Canada regulations, focusing on high-quality botanical extracts and specialized genetics for the medical and recreational sectors. Their business model encompasses the entire value chain from proprietary strain development via tissue culture to advanced CO2 extraction processes. Stonehedge Bioresources aims to provide standardized cannabinoid profiles to support therapeutic applications in pain management and neurology. The company also serves as a B2B supplier of starting materials and genetic intellectual property to other licensed producers in the industry. By leveraging advanced agricultural technology, they ensure consistency and purity in their biological products.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Stonehedge Bioresources.